RAPTEN FORTE
Modified-release tablet, 100mg
RxActive license
Active substance (INN)
diclofenac
Pharmaceutical form
Pharmaceutical formModified-release tablet
Strength100mg
PackagingUkupno 20 tableta sa modifikovanim oslobađanjem u blisteru (2x10) u kartonskoj kutiji
ManufacturerHemofarm a.d. Vršac, Serbia
Therapeutic groupMusculo-skeletal system (M01AB05)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJune 5, 2025
Analogs in Montenegro
20Other medicines with the same active substance
DICLOFENAC DUORx
Modified-release capsule, hard, 75mgDiclopramRx
Modified-release capsule, hard, 75mg + 20mgDiclopramRx
Modified-release capsule, hard, 75mg + 20mgDICLORAPIDRx
Gastro-resistant capsule, hard, 75mgDIKLOFENOTC
Gel, 10mg/gDIKLOFENRx
Gastro-resistant tablet, 50mgDIKLOFENRx
Prolonged-release tablet, 100mgDIKLOFENRx
Solution for injection, 75mg/3mlDIKLOFENRx
Suppository, 50mgDIKLOFENAK HFRx
Solution for injection/infusion, 75mg/3mlMAZENIDOTC
Gel, 10mg/gMAZENIDOTC
Gel, 10mg/gMAZENIDOTC
Gel, 10mg/gMAZENID FORTEOTC
Gel, 20mg/gMAZENID FORTEOTC
Gel, 20mg/gMAZENID FORTEOTC
Gel, 20mg/gNAKLOFEN® DUORx
Modified-release capsule, hard, 75mgRAPTENOTC
Gel, 10mg/gRAPTEN DUORx
Tablet, 75 mgRAPTEN FORTEOTC
Gel, 20mg/gSource: CInMED register